CB-211

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCB-211
Drug Alias NameHumaninCB-211
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2AtherosclerosisCardiovascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCohbar Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCohbar Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2AtherosclerosisCardiovascular Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A